[DNA flow cytometric analysis in primary breast cancer. S-phase and ploidy status as prognostic factors and their correlation to tumor-associated proteolytic factors].
Harbeck
N
N
Univers.-Frauenklinik d. TU München.
Schüren
E
E
Yamamoto
N
N
Pache
L
L
Schmitt
M
M
Jänicke
F
F
Dettmar
P
P
Höfler
H
H
Graeff
H
H
D001943:Breast Neoplasms / Q000401:mortality / Q000473:pathology*; D004273:DNA, Neoplasm / Q000032:analysis*; D005260:Female; D005434:Flow Cytometry; D006801:Humans; D009361:Neoplasm Invasiveness; D017395:Plasminogen Activator Inhibitor 1 / Q000032:analysis*; D011003:Ploidies; D016016:Proportional Hazards Models; D016196:S Phase / Q000502:physiology*; D015996:Survival Rate; D014568:Urokinase-Type Plasminogen Activator / Q000032:analysis*
D004273:DNA, Neoplasm; D017395:Plasminogen Activator Inhibitor 1; D014568:Urokinase-Type Plasminogen Activator
Durchflusszytometrische DNA-Analyse beim primären Mammakarzinom. S-Phase und Ploidität als Prognosefaktoren und ihre Korrelation zu tumorassoziierten Proteolysefaktoren.